Kite Pharma
VerifiedImmune-based therapies to treat cancer indications.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$11.9b (Public information from Aug 2017)
Santa Monica California (HQ)
Deals in current and previous year:
| EUR | 2015 | 2016 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | $0.0 | round |
| N/A | $0.0 | round | |
| investor investor | $0.0 | round | |
| investor | $0.0 | round | |
| N/A | $0.0 Valuation: $0.0 | round | |
| N/A | $0.0 | round | |
* | $11.9b Valuation: $11.9b | Acquisition | |
| Total Funding | 000k | ||
Related Content
Recent News about Kite Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Kite Pharma
Edit
exited
ACQUISITION by Kite Pharma Dec 2022
ACQUISITION by Clade Therapeutics Oct 2023
ACQUISITION Dec 2017
